Kuehn Law Encourages DSKE, RYZB, ROVR, and GRPH Investors to Contact Law Firm
Graphite Bio, Inc. (GRPH)
NASDAQ:AMEX Investor Relations:
alabamagraphite.com/investors-page
Company Research
Source: GlobeNewswire
NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: Daseke, Inc. (Nasdaq: DSKE) click to participate Daseke has agreed to be acquired by TFI International in a cash deal worth about $1.1 billion. Under the proposed transaction, Daseke shareholders will receive $8.30 per share in cash. RayzeBio, Inc. (Nasdaq: RYZB) click to participate Bristol Myers Squibb has agreed to purchase RayzeBio in an all-cash deal valued at around $4.1 billion. In accordance with the merger agreement, RayzeBio shareholders are set to receive $62.50 per share in cash. Rover Group, Inc. (Na
Show less
Read more
Impact Snapshot
Event Time:
GRPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRPH alerts
High impacting Graphite Bio, Inc. news events
Weekly update
A roundup of the hottest topics
GRPH
News
- LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress [Yahoo! Finance]Yahoo! Finance
- Graphite Bio, SCWorx, Acurx Pharmaceuticals among healthcare movers [Seeking Alpha]Seeking Alpha
- Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics [Yahoo! Finance]Yahoo! Finance
- Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz TherapeuticsBusiness Wire
- GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHBusiness Wire
GRPH
Earnings
- 11/13/23 - Miss
GRPH
Sec Filings
- 3/22/24 - Form 8-K
- 3/19/24 - Form 8-K
- 3/15/24 - Form SEC
- GRPH's page on the SEC website